Solid Biosciences Alternatives & Competitors
10 companies similar to Solid Biosciences — #TogetherWeAreSolid
Companies similar to Solid Biosciences
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
AskBio Inc.
Pioneering science to create transformative molecular medicines.
United States
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
San Diego, United States
Elixirgen Therapeutics, Inc.
Reimagine the Power of RNA
Baltimore, United States
Rival Readout
Competing with Solid Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Renovacor
Advancing transformative therapies for cardiovascular disease
Ultragenyx
Going Beyond Every Day
Novato, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
BridgeBio
We move at the speed of patient need.
Palo Alto, United States
Cytokinetics
Empowering Muscle Empowering Lives
South San Francisco, Unit...
About Solid Biosciences
Solid Biosciences, founded in 2013 and headquartered in Charlestown, MA, USA, is a trailblazer in the biotechnology sector, especially in precision genetic medicine. Their motto, #TogetherWeAreSolid, reflects their commitment to advancing gene therapy solutions for rare neuromuscular and cardiac diseases. Solid's innov...
Gene Therapy Development, Clinical Trials, Research Collaborations, Licensing Opportunities, Manufacturing Infrastructure
Patients with Rare Neuromuscular Diseases, Patients with Cardiac Diseases, Medical Researchers, Healthcare Providers, Biotechnology Collaborators
Precision Genetic Medicine, Gene Therapy, Rare Neuromuscular Diseases, Cardiac Diseases, Duchenne Muscular Dystrophy, Friedreich’s Ataxia, Catecholaminergic Polymorphic Ventricular Tachycardia, Dilated Cardiomyopathy, Genetic Regulators, Gene Therapy Delivery, Dystrophin Protein Restoration, Orphan Drug Designation, Rare Pediatric Disease Designation, Preclinical Program, Phase I/II Clinical Trial
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Solid Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Solid Biosciences on 9 Jun 2026. The 10 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
